Brand names and generic names
A brand name is a company's product. A generic name is the drug itself. This table matches each brand to its generic name and its approved use.
Why the difference matters. Ozempic and Wegovy both contain semaglutide, and Mounjaro and Zepbound both contain tirzepatide. Each pair is sold for different approved uses. The Atlas is generic-name-first, and every brand page links back to its generic page.
| Brand name | Generic name | Form | U.S. approved use | Status |
|---|---|---|---|---|
| Contrave | Naltrexone and bupropion | Daily tablet | Weight management | FDA-approved for weight management |
| Foundayo | Orforglipron | Daily tablet | Weight management | FDA-approved for weight management |
| Qsymia | Phentermine and topiramate | Daily capsule | Weight management | FDA-approved for weight management |
| Saxenda | Liraglutide | Daily injection | Weight management | FDA-approved for weight management |
| Wegovy | Semaglutide | Weekly injection | Weight management | FDA-approved for weight management |
| Wegovy HD | Semaglutide | Weekly injection (higher strength) | Weight management | FDA-approved for weight management |
| Wegovy pill | Semaglutide | Daily tablet | Weight management | FDA-approved for weight management |
| Zepbound | Tirzepatide | Weekly injection | Weight management | FDA-approved for weight management |
| Mounjaro | Tirzepatide | Weekly injection | Type 2 diabetes | FDA-approved, but not for obesity |
| Ozempic | Semaglutide | Weekly injection | Type 2 diabetes | FDA-approved, but not for obesity |
| Rybelsus | Semaglutide | Daily tablet | Type 2 diabetes | FDA-approved, but not for obesity |
| Victoza | Liraglutide | Daily injection | Type 2 diabetes | FDA-approved, but not for obesity |
Compounded versions are not FDA-approved products and are not listed here. Brand names for older medicines without a page of their own are found by searching the medication library.